BackSeaport Therapeutics Common Stock Overview

Seaport Therapeutics Common Stock Selling, General & Admin

Explore Seaport Therapeutics Common Stock's selling, general & admin with historical charts and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

Quarterly SG&A Expenses

$40.84M

As of Jun 30, 2026

Annual SG&A Expenses (TTM)

N/A

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Seaport Therapeutics Common Stock (SPTX) FAQ

Stockcircle tracks selling, general & admin for Seaport Therapeutics Common Stock (SPTX), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Selling, General & Admin page is built for Seaport Therapeutics Common Stock's historical SG&A expenses trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use SG&A expenses as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main SPTX overview so you can move from this figure to the surrounding analysis quickly.